Abstract
Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have